Our large observational study adds long-term survival to the mounting data supporting the use and safety of conservative surgery for low-risk, early-stage cervical carcinoma,” the researchers wrote.

Responses to an interview study demonstrated that patient education on palliative care led to better understanding of its benefits and greater utilization of these services.

Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease. 1 Because it is also one of the few cancers that can be largely ...

Meanwhile, another company focused on advanced cervical cancer is Nykode Therapeutics, its VB10.16 vaccine to treatment with Roche’s cancer immunotherapy Tecentriq reported in May this year to ...